Clinical Trial Update: Vitamin D Supplementation in Polymorphic Light Eruption [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating vitamin D supplementation for polymorphic light eruption was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymorphic Light Eruption

Drugs mentioned

• Vitamin D3 (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Medical University of Graz | Conditions: Polymorphic Light Eruption | Phase 3 | Status: TERMINATED